Geng, D., Zheng, L., Srivastava, R., Velasco-Gonzalez, C., Riker, A., Markovic, S. N., & Davila, E. (2010). Amplifying TLR-MyD88 signals within tumor-specific T-cells enhances antitumor activity to suboptimal levels of weakly-immunogenic tumor-antigens.
Chicago Style CitationGeng, Degui, Liqin Zheng, Ratika Srivastava, Cruz Velasco-Gonzalez, Adam Riker, Svetomir N. Markovic, i Eduardo Davila. Amplifying TLR-MyD88 Signals Within Tumor-specific T-cells Enhances Antitumor Activity to Suboptimal Levels of Weakly-immunogenic Tumor-antigens. 2010.
Cita MLAGeng, Degui, et al. Amplifying TLR-MyD88 Signals Within Tumor-specific T-cells Enhances Antitumor Activity to Suboptimal Levels of Weakly-immunogenic Tumor-antigens. 2010.
Atenció: Aquestes cites poden no estar 100% correctes.